Clinical trial
Impact of Erythropoietin Administration During Definitive Cervix Cancer…
NCT00348738 · Medical University of Vienna, Other · Unknown status
Key facts
| NCT number | NCT00348738 |
|---|---|
| Title | Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome |
| Official title | The Influence of the Pre-Therapeutic Increase in the Hemoglobin Level in the Blood Through Erythropoietin to the Therapy Results of the Primary Radiation Therapy for Carcinoma of the Cervix |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervix Cancer |
| Intervention type | Drug |
| Interventions | Erythropoietin |
| Enrollment | 300 |
| Start date | Jul 1, 2000 |
| Completion | Jul 1, 2009 |
| First posted | Jul 6, 2006 |
| Last update posted | Nov 2, 2007 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: